CrossrefInfokarte
CD14 monocyte PD-L1 and VEGF-A reductions are associated with improved survival after sintilimab plus DOX in advanced gastric cancer
Int. Journal of Clinical Pharmacology and Therapeutics · 2026-11-09
DOI: 10.5414/cp205039 ↗Abstract
Kein Abstract verfügbar.
EUVIMED